Anixa Gross Profit from 2010 to 2024

ANIX Stock

USD 3.30 0.01 0.30%

Anixa Biosciences Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 53.5 K in 2024. Gross Profit is the profit Anixa Biosciences makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

1986-01-31

Previous Quarter

-12 K

Current Value

-3 K

Quarterly Volatility

207.9 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.

Check out the analysis of Anixa Biosciences Correlation against competitors.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Anixa Biosciences over the last few years. Gross profit is a required income statement account that reflects total revenue of Anixa Biosciences minus its cost of goods sold. It is profit before Anixa Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Anixa Biosciences' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 127.5 K

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

Anixa Gross Profit Regression Statistics

	Arithmetic Mean	165,234,443
	Coefficient Of Variation	385.70
	Mean Deviation	307,163,141
	Median	127,498
	Standard Deviation	637,307,548
	Sample Variance	406160.9T
	Range	2.5B
	R-Value	0.25
	Mean Square Error	410776.4T
	R-Squared	0.06
	Significance	0.38
	Slope	35,160,852
	Total Sum of Squares	5686252.7T

Anixa Gross Profit History

	2024	53.5 K
	2023	56.4 K
	2022	49 K
	2021	2.5 B
	2020	127.5 K
	2019	-90.2 K
	2018	83.8 K

Other Fundumenentals of Anixa Biosciences

Gross Profit Margin

Anixa Biosciences Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Net Receivables	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Investments	Intangible Assets	Long Term Debt Total	Short Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	-0.55	-0.67	-0.29	0.99	-0.34	-0.61	0.81	-0.32	0.64	0.01	0.98	0.83	-0.48	-0.16	0.26	-0.49	0.95	0.95	0.92
Total Stockholder Equity	0.98		-0.59	-0.65	-0.46	1.0	-0.27	-0.63	0.8	-0.44	0.7	0.08	0.99	0.86	-0.43	-0.25	0.26	-0.55	0.93	0.94	0.92
Net Debt	-0.55	-0.59		0.29	0.41	-0.56	0.19	0.37	0.01	0.27	-0.34	0.14	-0.49	-0.46	0.03	0.26	-0.16	0.32	-0.62	-0.63	-0.37
Retained Earnings	-0.67	-0.65	0.29		0.12	-0.67	0.85	0.02	-0.59	0.34	-0.15	0.6	-0.67	-0.77	0.85	-0.08	-0.69	0.74	-0.58	-0.59	-0.67
Total Liab	-0.29	-0.46	0.41	0.12		-0.38	-0.25	0.35	-0.22	0.76	-0.59	-0.34	-0.42	-0.43	-0.09	0.51	-0.06	0.49	-0.25	-0.27	-0.32
Total Current Assets	0.99	1.0	-0.56	-0.67	-0.38		-0.3	-0.62	0.82	-0.39	0.68	0.05	0.99	0.85	-0.46	-0.2	0.27	-0.52	0.94	0.95	0.93
Net Receivables	-0.34	-0.27	0.19	0.85	-0.25	-0.3		-0.28	-0.2	0.04	0.26	0.84	-0.28	-0.41	0.81	-0.25	-0.6	0.49	-0.25	-0.27	-0.29
Accounts Payable	-0.61	-0.63	0.37	0.02	0.35	-0.62	-0.28		-0.52	0.26	-0.63	-0.55	-0.64	-0.44	-0.22	0.53	0.38	-0.06	-0.65	-0.65	-0.65
Short Term Investments	0.81	0.8	0.01	-0.59	-0.22	0.82	-0.2	-0.52		-0.29	0.59	0.19	0.86	0.71	-0.51	-0.11	0.18	-0.41	0.7	0.7	0.87
Common Stock	-0.32	-0.44	0.27	0.34	0.76	-0.39	0.04	0.26	-0.29		-0.55	-0.09	-0.43	-0.48	0.21	0.28	-0.29	0.62	-0.26	-0.28	-0.35
Property Plant Equipment	0.64	0.7	-0.34	-0.15	-0.59	0.68	0.26	-0.63	0.59	-0.55		0.54	0.71	0.57	0.04	-0.46	-0.08	-0.25	0.64	0.64	0.66
Current Deferred Revenue	0.01	0.08	0.14	0.6	-0.34	0.05	0.84	-0.55	0.19	-0.09	0.54		0.1	-0.05	0.55	-0.39	-0.54	0.36	0.06	0.05	0.13
Net Tangible Assets	0.98	0.99	-0.49	-0.67	-0.42	0.99	-0.28	-0.64	0.86	-0.43	0.71	0.1		0.86	-0.46	-0.27	0.23	-0.52	0.91	0.92	0.94
Capital Surpluse	0.83	0.86	-0.46	-0.77	-0.43	0.85	-0.41	-0.44	0.71	-0.48	0.57	-0.05	0.86		-0.53	-0.27	0.52	-0.61	0.85	0.86	0.93
Long Term Investments	-0.48	-0.43	0.03	0.85	-0.09	-0.46	0.81	-0.22	-0.51	0.21	0.04	0.55	-0.46	-0.53		-0.47	-0.78	0.72	-0.33	-0.34	-0.46
Intangible Assets	-0.16	-0.25	0.26	-0.08	0.51	-0.2	-0.25	0.53	-0.11	0.28	-0.46	-0.39	-0.27	-0.27	-0.47		0.53	-0.2	-0.24	-0.26	-0.29
Long Term Debt Total	0.26	0.26	-0.16	-0.69	-0.06	0.27	-0.6	0.38	0.18	-0.29	-0.08	-0.54	0.23	0.52	-0.78	0.53		-0.72	0.24	0.25	0.29
Short Term Debt	-0.49	-0.55	0.32	0.74	0.49	-0.52	0.49	-0.06	-0.41	0.62	-0.25	0.36	-0.52	-0.61	0.72	-0.2	-0.72		-0.36	-0.37	-0.44
Net Invested Capital	0.95	0.93	-0.62	-0.58	-0.25	0.94	-0.25	-0.65	0.7	-0.26	0.64	0.06	0.91	0.85	-0.33	-0.24	0.24	-0.36		1.0	0.91
Net Working Capital	0.95	0.94	-0.63	-0.59	-0.27	0.95	-0.27	-0.65	0.7	-0.28	0.64	0.05	0.92	0.86	-0.34	-0.26	0.25	-0.37	1.0		0.92
Capital Stock	0.92	0.92	-0.37	-0.67	-0.32	0.93	-0.29	-0.65	0.87	-0.35	0.66	0.13	0.94	0.93	-0.46	-0.29	0.29	-0.44	0.91	0.92

Click cells to compare fundamentals

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	56.4 K	53.5 K
Gross Profit Margin	0.27	0.25

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC